Present status of human HIV vaccine development.
Calarota
Sandra A
SA
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Weiner
David B
DB
D016915:AIDS Vaccines / Q000627:therapeutic use*; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation / Q000276:immunology; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D016207:Cytokines / Q000276:immunology; D004279:DNA, Viral / Q000276:immunology; D004196:Disease Outbreaks / Q000517:prevention & control*; D005260:Female; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D008253:Macaca mulatta; D008297:Male; D015302:Simian Immunodeficiency Virus / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D016207:Cytokines; D004279:DNA, Viral